Bal Pharma Limited (BALPHARMA) — Working Capital to Net Assets Ratio
Bal Pharma Limited (BALPHARMA) has a Working Capital to Net Assets ratio of 20.6% as of September 2025. Working capital of Rs161.13 Million (current assets of Rs2.45 Billion minus current liabilities of Rs2.29 Billion) is measured against net assets of Rs783.30 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Bal Pharma Limited balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Bal Pharma Limited Working Capital to Net Assets (2006–2025)
This chart shows how Bal Pharma Limited's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2006 to 2025. As of September 2025, the ratio stands at 20.6%, reflecting working capital of Rs161.13 Million against net assets of Rs783.30 Million INR. Check Bal Pharma Limited tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Bal Pharma Limited (2006–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Bal Pharma Limited from 2006 to 2025, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see BALPHARMA market cap.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 19.9% | Rs153.72 Million | Rs774.04 Million | Rs2.35 Billion | Rs2.20 Billion | ▼ -25.0 pp |
| 2024 | 44.9% | Rs311.04 Million | Rs692.61 Million | Rs2.34 Billion | Rs2.03 Billion | ▲ +15.4 pp |
| 2023 | 29.5% | Rs188.22 Million | Rs637.02 Million | Rs2.28 Billion | Rs2.09 Billion | ▼ -2.8 pp |
| 2022 | 32.4% | Rs189.26 Million | Rs584.92 Million | Rs1.85 Billion | Rs1.66 Billion | ▲ +10.6 pp |
| 2021 | 21.8% | Rs116.14 Million | Rs533.54 Million | Rs1.64 Billion | Rs1.53 Billion | ▲ +18.2 pp |
| 2020 | 3.6% | Rs16.38 Million | Rs453.38 Million | Rs1.61 Billion | Rs1.59 Billion | ▼ -27.4 pp |
| 2019 | 31.0% | Rs186.69 Million | Rs602.21 Million | Rs1.82 Billion | Rs1.63 Billion | ▼ -20.1 pp |
| 2018 | 51.1% | Rs307.35 Million | Rs602.01 Million | Rs1.76 Billion | Rs1.45 Billion | ▼ -15.5 pp |
| 2017 | 66.5% | Rs399.37 Million | Rs600.31 Million | Rs1.61 Billion | Rs1.21 Billion | ▲ +8.4 pp |
| 2016 | 58.1% | Rs318.06 Million | Rs547.22 Million | Rs1.43 Billion | Rs1.11 Billion | ▲ +35.0 pp |
| 2015 | 23.1% | Rs127.66 Million | Rs551.68 Million | Rs1.05 Billion | Rs923.58 Million | ▲ +6.5 pp |
| 2014 | 16.7% | Rs83.45 Million | Rs500.50 Million | Rs951.17 Million | Rs867.72 Million | ▲ +15.4 pp |
| 2013 | 1.2% | Rs5.48 Million | Rs446.18 Million | Rs932.14 Million | Rs926.66 Million | ▲ +5.8 pp |
| 2012 | -4.5% | Rs-18.21 Million | Rs400.56 Million | Rs844.97 Million | Rs863.18 Million | ▼ -132.6 pp |
| 2011 | 128.0% | Rs463.12 Million | Rs361.75 Million | Rs809.00 Million | Rs345.88 Million | ▲ +12.2 pp |
| 2010 | 115.8% | Rs414.20 Million | Rs357.62 Million | Rs692.04 Million | Rs277.84 Million | ▲ +35.5 pp |
| 2009 | 80.3% | Rs299.08 Million | Rs372.35 Million | Rs612.54 Million | Rs313.46 Million | ▼ -18.4 pp |
| 2008 | 98.8% | Rs346.01 Million | Rs350.32 Million | Rs582.65 Million | Rs236.64 Million | ▲ +48.7 pp |
| 2007 | 50.1% | Rs167.21 Million | Rs334.02 Million | Rs548.08 Million | Rs380.87 Million | ▼ -5.3 pp |
| 2006 | 55.3% | Rs178.73 Million | Rs323.02 Million | Rs589.65 Million | Rs410.91 Million | — |